Michele Ritter

498 total citations
10 papers, 253 citations indexed

About

Michele Ritter is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Michele Ritter has authored 10 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Michele Ritter's work include Retinal and Optic Conditions (2 papers), Telemedicine and Telehealth Implementation (2 papers) and COVID-19 Clinical Research Studies (2 papers). Michele Ritter is often cited by papers focused on Retinal and Optic Conditions (2 papers), Telemedicine and Telehealth Implementation (2 papers) and COVID-19 Clinical Research Studies (2 papers). Michele Ritter collaborates with scholars based in United States and Vietnam. Michele Ritter's co-authors include L. Pirofski, Saima Aslam, Florin Vaida, Ravindra L. Mehta, Divya P. Prajapati, David L. Goldman, Adam S. DeConde, Carol H. Yan, Thomas Martin and Stephanie M. LaVergne and has published in prestigious journals such as Journal of the American Society of Nephrology, Otolaryngology and BMC Infectious Diseases.

In The Last Decade

Michele Ritter

9 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Ritter United States 7 85 62 51 43 36 10 253
Katherine H. Flanagan United States 9 81 1.0× 37 0.6× 200 3.9× 39 0.9× 7 0.2× 11 505
Khadija Boussetta Tunisia 10 65 0.8× 63 1.0× 76 1.5× 53 1.2× 13 0.4× 41 345
Ottavio Ziino Italy 14 147 1.7× 50 0.8× 104 2.0× 33 0.8× 19 0.5× 29 640
David M. Manthei United States 11 62 0.7× 40 0.6× 236 4.6× 17 0.4× 42 1.2× 31 442
Katja Masjosthusmann Germany 10 63 0.7× 55 0.9× 58 1.1× 7 0.2× 14 0.4× 25 267
Laurine Bow United States 11 48 0.6× 48 0.8× 81 1.6× 27 0.6× 6 0.2× 20 487
Elena Seoane Spain 10 60 0.7× 18 0.3× 93 1.8× 18 0.4× 9 0.3× 16 453
Francis M. Williams United States 7 169 2.0× 18 0.3× 44 0.9× 11 0.3× 18 0.5× 9 365
Susanne Schinke Germany 10 60 0.7× 301 4.9× 75 1.5× 9 0.2× 14 0.4× 23 475
Ásbjörn Sigfússon Iceland 11 71 0.8× 38 0.6× 19 0.4× 24 0.6× 9 0.3× 23 408

Countries citing papers authored by Michele Ritter

Since Specialization
Citations

This map shows the geographic impact of Michele Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Ritter more than expected).

Fields of papers citing papers by Michele Ritter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Ritter. The network helps show where Michele Ritter may publish in the future.

Co-authorship network of co-authors of Michele Ritter

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Ritter. A scholar is included among the top collaborators of Michele Ritter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Ritter. Michele Ritter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Behnke, Alexander, et al.. (2023). Classification of Patient Recovery From COVID-19 Symptoms Using Consumer Wearables and Machine Learning. IEEE Journal of Biomedical and Health Informatics. 27(3). 1271–1282. 5 indexed citations
2.
Chan, Alison, Michele Ritter, & Mathieu F. Bakhoum. (2021). Bilateral cotton wool spots after ambulatory COVID-19. International Journal of Infectious Diseases. 105. 414–415.
3.
Rempe, Torge, et al.. (2021). CNS Lymphocytic Vasculitis in a Young Woman With COVID-19 Infection. Neurology Neuroimmunology & Neuroinflammation. 8(5). 16 indexed citations
4.
Horton, Lucy E., et al.. (2020). 474. Using telemedicine to provide virtual care for COVID-19 patients at home. Open Forum Infectious Diseases. 7(Supplement_1). S303–S303. 1 indexed citations
5.
Yan, Carol H., Divya P. Prajapati, Michele Ritter, & Adam S. DeConde. (2020). Persistent Smell Loss Following Undetectable SARS‐CoV‐2. Otolaryngology. 163(5). 923–925. 16 indexed citations
6.
Martin, Thomas, et al.. (2018). Pasteurella multocida line infection: a case report and review of literature. BMC Infectious Diseases. 18(1). 420–420. 16 indexed citations
7.
Aslam, Saima, Florin Vaida, Michele Ritter, & Ravindra L. Mehta. (2014). Systematic Review and Meta-Analysis on Management of Hemodialysis Catheter-Related Bacteremia. Journal of the American Society of Nephrology. 25(12). 2927–2941. 58 indexed citations
8.
Patel, Nishant, William Y. Shi, Michael A. Liss, et al.. (2014). Multidrug Resistant Bacteriuria Before Percutaneous Nephrolithotomy Predicts for Postoperative Infectious Complications. Journal of Endourology. 29(5). 531–536. 21 indexed citations
9.
Ritter, Michele & David L. Goldman. (2009). Pharmacotherapy of cryptococcosis. Expert Opinion on Pharmacotherapy. 10(15). 2433–2443. 8 indexed citations
10.
Ritter, Michele & L. Pirofski. (2009). Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transplant Infectious Disease. 11(4). 290–297. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026